
Excellence in Pediatrics is a non-profit
global network dedicated to advancing
pediatric healthcare.
Rue des Vignerons 18, 1110 Morges 1 (VD), Switzerland
Dr. François Eyskens is a Professor at the Centrum Erfelijke Metabole Aandoeningen (CEMA) and an expert in hereditary metabolic disorders. He is affiliated with the University of Antwerp, where he plays a key role in advancing research and clinical care for rare metabolic diseases.
Dr. Eyskens has been involved in the diagnosis and treatment of inherited metabolic diseases since 1991. He serves as a clinical expert, principal investigator, and coordinator of an expert center specializing in metabolic disorders. His work focuses on improving diagnostic accuracy, treatment strategies, and patient outcomes for conditions such as Fabry disease, metachromatic leukodystrophy, and other lysosomal storage disorders.
He has led multinational clinical trials, contributing to the development of innovative therapies for rare diseases. His research includes studies on enzyme replacement therapy, novel treatment approaches, and the long-term safety and efficacy of emerging drugs. His work is instrumental in shaping therapeutic protocols for patients with metabolic disorders, ensuring they receive the most effective treatments available.
Beyond his research, Dr. Eyskens is actively involved in medical education and mentorship, training healthcare professionals in the complexities of metabolic disorders. He is an associated professor at the University of Antwerp, where he contributes to the Department of Medicine and the Laboratory of Experimental Medicine and Pediatrics. His teaching focuses on metabolic diseases, pediatric neurology, and rare disease management, equipping future clinicians with the knowledge needed to improve patient care.
Dr. Eyskens also coordinates the Centre of Metabolic Diseases (CEMA) at the Antwerp University Hospital (UZA), overseeing a multidisciplinary team that includes dietitians, clinical psychologists, and child neurologists. This collaborative approach ensures comprehensive care for patients with metabolic disorders, addressing both medical and psychological aspects of their conditions.
Engage with leading academics, experts, researchers, and healthcare innovators presenting the latest advancements in their fields.
See Faculty